Elevance Health - AI Stock Analysis

Analysis generated November 4, 2025

Elevance Health, previously known as Anthem, Inc., is a prominent player in the health insurance industry, offering a variety of insurance products and services. Through its various subsidiaries, Elevance Health serves millions of customers across the United States. The company’s strong market presence and extensive range of services make it a key player in the healthcare sector.

Elevance Health has positioned itself as a comprehensive healthcare provider, aiming to deliver better health outcomes at lower costs to its members. With a robust portfolio of health plans and significant scale, Elevance Health continues to navigate changes in the healthcare landscape, emphasizing efficiency and quality care.

Fundamental Analysis

Analyzing Elevance Health’s recent financial performance reveals a mixed picture. The revenue for the last quarter was $50.7 billion, a 1.88% increase from the previous quarter and a 12.33% increase year-over-year. These figures suggest consistent growth in top-line revenue.

However, there are some concerns regarding profitability. The net income for the last quarter was $1.19 billion, which denotes a 31.78% decrease compared to the previous quarter, despite showing a 17.03% increase year-over-year. This quarterly drop in net income signals potential issues with cost management or other operational inefficiencies.

EBITDA for the last quarter stood at $1.76 billion, reflecting a 41.69% decrease from the previous quarter and a 12.24% decrease compared to the same quarter last year. This declining trend indicates significant profitability challenges.

The company's Price-to-Earnings (P/E) ratio is 12.92, which falls within a normal range. This ratio doesn't indicate an overvalued or undervalued status distinctly, but it suggests that the stock is reasonably priced compared to its earnings.

Technical Analysis

The stock price of Elevance Health is currently at $316.03, marking a 9.83% decline in the last month and a 22.96% decline over the past year. Such a downward trajectory raises concerns about the company's short-term performance.

The bearish trend is further supported by the 10-day Simple Moving Average (SMA10) at $326.34, which is lower than the previous SMA10 of $328.97. This indicates ongoing negative momentum in the stock price.

Additionally, the Relative Strength Index (RSI) is at 27.5, suggesting that the stock may be oversold. An RSI below 30 is generally considered a signal that the stock is undervalued and could potentially rebound in the near term.

Alternative Data Analysis

Alternative data paints a rather cautious picture for Elevance Health. The company has 535 open job positions, a 42% decrease in recent months, indicating efforts to cut costs, which is not a favorable sign for growth-oriented companies.

Employee sentiment towards the company is neutral, reflecting neither optimism nor pessimism within the workforce.

Customer acquisition metrics show a worrisome trend. Elevance Health’s website sees an estimated 360,000 visitors, down by 31% in recent months. This drop in web traffic could signal declining customer interest or market penetration.

The company's mobile app downloads have also remained stagnant, indicating a lack of digital engagement or growth in its user base. On social media, Elevance Health maintains 34,000 followers on Twitter with no notable change recently, suggesting stable but uninspiring customer engagement.

Significantly, AltIndex’s AI score for Elevance Health is 38, which is a sell signal. This comprehensive score, synthesizing fundamental, technical, and alternative data, suggests that the stock may face headwinds in the near term.

Conclusion

In conclusion, Elevance Health's financials show a mixed scenario, with positive revenue growth but concerning declines in profitability metrics. The technical indicators also point towards a bearish market sentiment and a potentially oversold stock. The alternative data further highlights conservative hiring practices, declining website traffic, and stagnant customer engagement, culminating in an AI score indicating a potential sell.

Given these factors, evaluating Elevance Health from a broad perspective suggests a cautious approach. The company has notable strengths in market presence and revenue growth but faces significant challenges in profitability and customer engagement. As such, potential investors should weigh these elements carefully, keeping an eye on cost management and market trends before making any investment decisions.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.